Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


New light on kala-azar

Biologists have discovered a virus-carrying microbe, a close relative of the leishmania parasite, along with the leishmania parasite in kala-azar victims – a finding that may provide new leads for understanding and devising better ways to treat this disease and its complications such as post kala-azar dermal leishmaniasis1.

In recent years, Leishmania donovani , the parasite that causes kala-azar, has developed resistance to antimonial drugs. The other co-infecting pathogens, such as human immunodeficiency virus, have been found to intensify the burden of this disease, particularly in developing countries like India.

Scientists from the CSIR-Indian Institute of Chemical Biology, Kolkata and Banaras Hindu University, Varanasi, led by Subhajit Biswas, identified Leptomonas seymouri , a virus-carrying microbe in most of the blood samples of kala-azar patients.

The studied samples contained both drug-sensitive and drug-resistant leishmania parasites. The researchers say that the virus can activate specific immune cells, triggering the host’s innate immune responses. This, in turn, might aggravate kala-azar and post kala-azar complications.

This work will possibly encourage further research towards the development of virus vaccines and antivirals for the management of kala-azar and its complications, says Biswas.



  1. Sukla, S. et al. Leptomonas seymouri narna-like virus 1 and not leishmania viruses detected in kala-azar samples from India. Arch. Virol. 162, 3827-3835 (2017)

    Google Scholar 

Download references

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links